Flubrotizolam
![]() | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H10BrFN4S |
| Molar mass | 377.24 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Flubrotizolam (2-bromo-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) is a thienotriazolodiazepine derivative with potent sedative and anxiolytic effects, which has been sold as a designer drug.[1][2][3]
See also
References
- ↑ US 4094984, Weber KH, Bauer A, Danneburg P, Kuhn FJ, "6-Phenyl-8-bromo-4H-s-triazolo-[3,4C]-thieno-[2,3E]-1,4-diazepines and salts thereof.", published 1978-06-13, issued 13 June 1978, assigned to Boehringer Ingelheim and Boehringer Ingelheim GmbH
- ↑ Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, et al. (July 2021). "The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity". Pharmaceuticals. 14 (8). Basel, Switzerland: 720. doi:10.3390/ph14080720. PMC 8398354. PMID 34451817.
- ↑ Catalani V, Floresta G, Botha M, Corkery JM, Guirguis A, Vento A, et al. (January 2023). "In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines". Chemical Biology & Drug Design. 101 (1): 40–51. doi:10.1111/cbdd.14119. hdl:2299/25749. PMID 35838189. S2CID 250559695.
- ↑ Gameli PS, Kutzler J, Berardinelli D, Carlier J, Auwärter V, Busardò FP (September 2024). "Exploring the Metabolism of Flubrotizolam, a Potent Thieno-Triazolo Diazepine, Using Human Hepatocytes and High-Resolution Mass Spectrometry". Metabolites. 14 (9): 506. doi:10.3390/metabo14090506. PMC 11433749. PMID 39330513.
- ↑ "Document Viewer". www.korea.kr. Retrieved 2026-07-06.
